Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)NCT05269355PTC TherapeuticsPhase 2, Phase 3Terminated2024-06-17Actual
Safety, PK and Efficacy of PCS12852 on Gastric Emptying Rate in Patients With Moderate to Severe GastroparesisNCT05270460Processa PharmaceuticalsPhase 2Completed2022-09-29Actual
An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 StudyNCT05271370CytoDyn, Inc.Phase 2, Phase 3Terminated2022-06-20Actual
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)NCT05271552BioXcel Therapeutics IncPhase 3Completed2023-04-21Actual
A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckNCT05271604BioAtla, Inc.Phase 2Completed2025-09-22Actual
A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL Taken Daily in Patients With FibromyalgiaNCT05273749Tonix Pharmaceuticals, Inc.Phase 3Completed2023-11-14Actual
A Study of Sapanisertib in Relapsed/Refractory NFE2L2-Mutated and Wild-Type Squamous Non-Small Cell Lung CancerNCT05275673Faeth TherapeuticsPhase 2Terminated2023-01-24Actual
An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With DementiaNCT05276830BioXcel Therapeutics IncPhase 2Terminated2022-04-01Actual
ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)NCT05279417ACRSPhase 2Completed2023-09-05Actual
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable TumorsNCT05280314IO BiotechPhase 2Recruiting2025-04-30Estimated
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)NCT05281471Genelux CorporationPhase 3Recruiting2026-12Estimated
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge TestNCT05282797Anebulo PharmaceuticalsPhase 2Completed2023-08-26Actual
Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic SeizuresNCT05288283Jazz PharmaceuticalsPhase 3Terminated2023-09-28Actual
A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.NCT05288504AVTXPhase 2Completed2023-05-11Actual
Voclosporin in Adolescent and Pediatric Subjects With Lupus NephritisNCT05288855AUPHPhase 3Terminated2025-07-03Actual
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)NCT05291091EWTXPhase 2Completed2026-09-07Actual
Efficacy and Safety of ALT-801 in the Treatment of ObesityNCT05295875ALTPhase 2Completed2023-09-28Actual
A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.NCT05296629Journey Medical CorporationPhase 3Completed2023-06-30Actual
Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older AdultsNCT05297578PCVXPhase 2Completed2023-02-15Actual
A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid MalignanciesNCT05301517Kyntra BioPhase 3Completed2023-04-03Actual
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I DisorderNCT05303064Alkermes, Inc.Phase 3Recruiting2027-12Estimated
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)NCT05303519NUVBPhase 3Recruiting2028-12-01Estimated
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1)NCT05306574Vor BiopharmaPhase 3Terminated2025-01-06Actual
Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPPNCT05308472IRONPhase 2Completed2024-02-20Actual
The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderNCT05312151COMPASS PathwaysPhase 2Completed2024-02-12Actual
Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis ImperfectaNCT05312697RAREPhase 2Terminated2022-07-07Actual
A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled HypertensionNCT05314439IONSPhase 2Completed2023-01-31Actual
Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular CarcinomaNCT05317819Polaris GroupPhase 3Recruiting2028-09Estimated
A Study to Evaluate the Effects of SAGE-718 in Participants With Parkinson's Disease Cognitive ImpairmentNCT05318937SUPNPhase 2Completed2024-01-17Actual
A Study of XPro1595 in Patients With Early Alzheimer's Disease With Biomarkers of InflammationNCT05318976INMBPhase 2Completed2025-05-12Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.